Abstract
Background The DOC screen was developed to identify Depression, Obstructive sleep apnea, and Cognitive impairment (“DOC” comorbidities) after stroke. Each component has its own score, but additional information may be gained from the time to complete the screen. Cognitive screening completion time is rarely used as an outcome measure. We assessed the added value of using DOC screen completion time as a predictor of impairment on detailed cognitive assessments.
Methods Consecutive English-speaking new referrals to the stroke prevention clinic were consented to participate in detailed neuropsychological testing (n=437). DOC screen scores and times were compared to cognitive test scores using multiple linear regression and receiver operating characteristic (ROC) analysis. All linear regression analyses controlled for age, sex, years of education, and functional outcome as assessed by the modified Rankin score.
Results Average completion time for the DOC screen was 3.8 ± 1.3 minutes. After accounting for age, sex and cognitive screen score, completion time was a significant independent predictor, of speed of processing (p = .002, 95% CI: -0.016 to -0.004), verbal fluency (p < .001, CI: -0.012 to -0.006) and executive (p = .004, CI: -0.006 to -0.001), but not memory, function. Completion time above 5.5 minutes (332.5 seconds) was associated with a high likelihood of impairment on gold standard executive (likelihood ratios 3.9-5.2) and speed of processing (likelihood ratio = 5.2) tasks.
Conclusions DOC screen completion time is easy to collect in routine care and is independently associated with speed of processing, language and executive dysfunctions after stroke. People who take more than 5.5 minutes to complete the DOC screen are likely to have deficits in executive functioning and speed of processing. These domains can be challenging to screen for in stroke survivors, and this measure provides a simple, clinically feasible method to screen for these under-appreciated concerns.
Clinical Trials Registration Identifier: NCT02363114
Clinical Trials URL: https://clinicaltrials.gov/ct2/show/NCT02363114
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Clinical Trials Registration Identifier: NCT02363114
Funding Statement
This study was supported by CIHR (Grant Ref No. 137038) and HSF (Project No. 000392). RHS received salary support for research from an Ontario Clinician Scientist (Phase II) Award from Heart and Stroke, and from the Department of Medicine (Neurology) at Sunnybrook and University of Toronto. In-kind support for data storage was provided by the Ontario Brain Institute and the Ontario Neurodegenerative Disease Research Initiative (ONDRI).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Sunnybrook Research Ethics Board.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Data Availability
All data is not available. DOC screening was performed as part of clinical care and used for research under REB approval with waiver of consent, on the condition of restricted data sharing.
Non-Standard Abbreviations and Acronyms
- CVLT
- California Verbal Learning Test
- DOC
- Depression, Obstructive Sleep Apnea, Cognitive Impairment
- MMSE
- Mini Mental State Examination
- MoCA
- Montreal Cognitive Assessment
- OSA
- Obstructive Sleep Apnea
- QCT
- Question Completion Time
- TMT
- Trail Making Test